Cargando…

Clinical predictors of kynurenine pathway aberrations in schizophrenia and bipolar disorder

INTRODUCTION: Schizophrenia and bipolar disorder are severe mental illnesses that are known to have a considerable overlap in underlying pathophysiological mechanisms. More specifically, disturbances in the kynurenine pathway have been hypothesized as processes bridging altered immune responses and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skorobogatov, K., Leboyer, M., Foiselle, M., Morrens, M., De Picker, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567525/ http://dx.doi.org/10.1192/j.eurpsy.2022.927

Ejemplares similares

Kynurenine pathway abnormalities are state-specific but not diagnosis-specific in schizophrenia and bipolar disorder
por: Skorobogatov, Katrien, et al.
Publicado: (2023)

Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders
por: Skorobogatov, Katrien, et al.
Publicado: (2021)

Tryptophan Catabolites in Bipolar Disorder: A Meta-Analysis
por: Hebbrecht, Kaat, et al.
Publicado: (2021)

The kynurenine pathway in schizophrenia, bipolar disorder, and major depressive disorder: a systematic review and meta-analysis of cerebrospinal fluid studies
por: Salagre, E., et al.
Publicado: (2023)

Overlapping of clinical symptoms between schizophrenia and bipolar disorder
por: Tahirovic, A., et al.
Publicado: (2022)

HLA-E circulating and genetic determinants in schizophrenia and bipolar disorder
por: Boukouaci, Wahid, et al.
Publicado: (2021)

Identification of inflammatory subgroups of schizophrenia and bipolar disorder patients with HERV-W ENV antigenemia by unsupervised cluster analysis
por: Tamouza, Ryad, et al.
Publicado: (2021)

Decreased plasma concentrations of kynurenine and kynurenic acid in schizophrenia patients
por: Markovic, M., et al.
Publicado: (2023)

Correction: Identification of inflammatory subgroups of schizophrenia and bipolar disorder patients with HERV-W ENV antigenemia by unsupervised cluster analysis
por: Tamouza, Ryad, et al.
Publicado: (2021)

The association of kynurenine pathway metabolites with symptom severity and clinical features of bipolar disorder: An overview
por: Bartoli, Francesco, et al.
Publicado: (2022)

Imbalanced Kynurenine Pathway in Schizophrenia
por: Kegel, Magdalena E, et al.
Publicado: (2014)

Exploring the association among the tryptophan to serotonin and kynurenine pathways, cognition and suicidal behaviour: a secondary analysis in a sample of individuals affected by Bipolar Disorder.
por: Paribello, P., et al.
Publicado: (2023)

The response to unfolded proteins in schizophrenia and bipolar disorder
por: Cachán, C., et al.
Publicado: (2023)

The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies
por: Inam, Mehmet Enes, et al.
Publicado: (2023)

Identifying prodromal biomarkers for schizophrenia and bipolar disorder using magnetoencephalography
por: Jefsen, O., et al.
Publicado: (2022)

Tracking TRYCAT: A Critical Appraisal of Kynurenine Pathway Quantifications in Blood
por: Coppens, Violette, et al.
Publicado: (2022)

The Kynurenine Pathway and Bipolar Disorder: Intersection of the Monoaminergic and Glutamatergic Systems and Immune Response
por: Kadriu, Bashkim, et al.
Publicado: (2019)

Involvement of Kynurenine Metabolism in Bipolar Disorder: An Updated Review
por: Zhang, Peifen, et al.
Publicado: (2021)

Predictors of psychosocial functioning in euthymic patients with bipolar disorder
por: Ajmi, S., et al.
Publicado: (2023)

The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis
por: Morrens, M., et al.
Publicado: (2022)

Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations
por: De Picker, Livia, et al.
Publicado: (2020)

Predictors of functional impairment in patients with bipolar disorder
por: Kartal, C., et al.
Publicado: (2022)

Antipsychotics and mood stabilizers on risk for hepatic failure in people with schizophrenia and bipolar disorder
por: Tascón Guerra, M.F., et al.
Publicado: (2022)

S96. CARDIOVASCULAR DISEASE RISK IN PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER
por: Rødevand, Linn, et al.
Publicado: (2018)

The effect of long-acting injectable antipsychotics on QRISK3 in patients with bipolar disorder and schizophrenia
por: Erbasan, V., et al.
Publicado: (2023)

Prevalence and nature of childhood trauma among patients with schizophrenia and bipolar affective disorder
por: Abdelkarim, A. M., et al.
Publicado: (2023)

Evolution of some liver function markers after treatment in patients with schizophrenia and bipolar disorder
por: Sellami, S., et al.
Publicado: (2023)

Clinical and evolutionary features of bipolar disorder in women
por: Tfifha, M., et al.
Publicado: (2021)

Clinical and biological features associated to bipolar disorder with comorbid migraine: results from the FACE-BD cohort
por: Patoz, M.-C., et al.
Publicado: (2023)

Variation in cognitive insight processes between schizophrenia and bipolar disorder in a Tunisian population
por: Ben Hmida, M.
Publicado: (2022)

Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia
por: Ruderfer, Douglas M., et al.
Publicado: (2013)

A disorder in executive functions crosses traditional diagnostic borders of the schizophrenia-bipolar spectrum
por: Szendi Md Habil, I., et al.
Publicado: (2022)

Orexins in the clinical course of bipolar disorder
por: Moya-Lacasa, C., et al.
Publicado: (2021)

Exploring the Psychosis Functional Connectome: Aberrant Intrinsic Networks in Schizophrenia and Bipolar Disorder
por: Calhoun, Vince D, et al.
Publicado: (2012)

The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis
por: Almulla, Abbas F., et al.
Publicado: (2022)

5.3 EVIDENCE ON A TRANSDIAGNOSTIC PSYCHOSIS SPECTRUM OF SCHIZOPHRENIA, SCHIZOAFFECTIVE AND PSYCHOTIC BIPOLAR DISORDER IN THE BIPOLAR-SCHIZOPHRENIA NETWORK ON INTERMEDIATE PHENOTYPES (B-SNIP)
por: Reininghaus, Ulrich, et al.
Publicado: (2018)

Clinical Correlates of Cardiac Conduction in Bipolar Disorder
por: Prieto, M., et al.
Publicado: (2022)

Clinical effects of Cariprazine and their relationship with polymorphisms of dopamine and serotonin receptors: preliminary results from a prospective study on schizophrenia and bipolar disorder
por: De Pieri, M., et al.
Publicado: (2022)

Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder
por: Birner, Armin, et al.
Publicado: (2017)

Combating Age-Associated Immune Decline Using Kynurenine Pathway Interventions
por: Espejo, Luis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jkjl1dvfgpnsg6ukqmgjn6g6u9